期刊文献+

顺铂增加人Hela细胞放疗敏感性涉及细胞周期的研究 被引量:2

Study on cisplatin′s effects on the enhancement of the sensitivity of radiotherapy of human Hela cell lines through cell-cycle kinetics
下载PDF
导出
摘要 目的 探讨小剂量顺铂增加人Hela细胞对电离辐射敏感性涉及细胞周期动力学的机理。方法 将Hela细胞分为空白对照组、单纯放疗组、单纯化疗组和放疗加化疗组 ,用流式细胞仪测定细胞凋亡率和细胞周期变化 ,采用SP免疫组化法检测Hela细胞受作用后p5 3基因蛋白表达情况。结果 单纯放疗、单纯化疗均可诱导Hela细胞凋亡 ,而放疗加化疗组细胞凋亡率明显增加 ,经顺铂作用后 ,Hela细胞周期发生明显变化 ,表现为G1期减少、S期和G2 /M期增加 ,突变型 p5 3表达减弱。结论 小剂量顺铂可通过改变培养的人Hela细胞周期 ,诱导细胞G2 /M期延迟从而提高放疗敏感性 ,可能与其内在的 p5 3基因表达改变有关。 Objective To investigate low dose cisplatin in the enhance inout of the sensitivity of radiotherapy of human Hela cell lines throuth adjusting cell-cycle kinetics.Methods The Hela cells were divided into four groups(control group,radiation only,chemotherapy only,radiation and chemotherapy),flow-cytometry was introduced in the study of the cell cycles and apoptosis of Hela cells,and immunohistochemistry of p53 protein.Results Radiation and chemotherapy both could induce Hela cells apoptosis,cisplatin could obviously enhance Hela cells apoptosis induced by radiation,and cisplatin could change cell-cycle of Hela cell lines,G_1 phase cells decrease and G_2/M phase cells increase.Conclusion Low dose cisplatin can enhance the sensitivity of radiotherapy through change cell cycle of Hela cell lines.
出处 《江苏医药》 CAS CSCD 北大核心 2002年第11期820-821,F002,共3页 Jiangsu Medical Journal
关键词 顺铂 HELA细胞 放疗敏感性 细胞周期 免疫组织化学 肿瘤 Cisplatin Radiosensitivity Cell-cycle Immunohistochemistry
  • 相关文献

同被引文献17

  • 1[1]Elmore E,Luc TT,Steele VE,et al.Comparative tissue-specific toxicities of 20 cancer preventive agents using cultured cells from 8 different normal human epithelia.In Vitr Mol Toxicol,2001,14(3):191-207.
  • 2[2]Simeone AM,Deng CX,Kelloff GJ,et al.N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.Carcinogenesis,2005,26(5):1000-1007.
  • 3[3]Zou C,Vlastos AT,Yang L,et al.Effect of 4-hydroxyphenylretinamide on human cervical epithelial and cancer cell lines.J Soc Gynecol Investig,2003,10(1):41-48.
  • 4[4]Golubkov V,Garcia A,Markland FS.Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.Anticancer Re,2005,25(1A):249-253.
  • 5[5]S.Y.Sun,W.Li,P.Yue,et al.Mediation of N-(4-hydoxyphenyl)retinamideinduced apoptosis in human cancer cells by different mechanisms.Cancer Res,1999,59:2493-2498.
  • 6[6]Holmes WF,Soprano DR,Soprano KJ.Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.J Cell Biochem,2003,89(2):262-278.
  • 7[7]Andrea Decensi,Davide Serrano,Bernardo Bonanni,et al.Breast Cancer Prevention Trials Using Retinoids.J Mammary Gland Biol Neoplasia,2003,8(1):19-30.
  • 8[8]Paulson JD,Oldham JW,Preston RF,et al.Lack of genotoxicity of the cancer chemopreventive agent (4-hydroxyphenyl) retinamide.Fundam Appl Toxicol,1985,5(1):144-150.
  • 9Cooper MA, Bush J E, Fehniger TA, et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells [J ]. Blood, 2002, 100 (10): 3633- 3638.
  • 10Chu G.Cellular responses to eisplatin: the roles of DNA-binding proteins and DNA repair [.J]. J Biol Chem, 1994, 269: 787-790.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部